United States

People: Neurocrine Biosciences Inc (NBIX.O)

NBIX.O on Nasdaq

16 Aug 2017
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Grigoriadis, Dimitri 

Dr. Dimitri E. Grigoriadis, Ph.D., serves s Chief Research Officer of Neurocrine Biosciences Inc., since January 2007. He became Chief Research Officer in January 2007 and oversees all research functions, including drug discovery, biology and chemistry. Dr. Grigoriadis joined Neurocrine in 1993, established the pharmacology and drug screening groups and was most recently a Neurocrine Fellow and Vice President of Discovery Biology. Prior to joining Neurocrine, he was a Senior Scientist in the Neuroscience group at the DuPont Pharmaceutical Company from 1990 to 1993. Dr. Grigoriadis received his B.Sc. from the University of Guelph in Ontario, Canada, and his M.Sc. and Ph.D. in Pharmacology from the University of Toronto, Ontario, Canada. He conducted his postdoctoral research at the National Institute on Drug Abuse from 1987 to 1990.

Basic Compensation

Total Annual Compensation, USD 529,760
Restricted Stock Awards, USD 1,723,920
Long-Term Incentive Plans, USD --
All Other, USD 1,072,200
Fiscal Year Total, USD 3,325,880

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised 77,500 1,309,280.00